idoven.ai: Revolutionizing Cardiac Care with AI-Powered ECG Analysis

idoven.ai is a cutting-edge cardiology-as-a-service platform that leverages artificial intelligence to enable rapid, accurate, and scalable detection, triage, and diagnosis of cardiac conditions. Built on a foundation of over 1.25 million hours of manually annotated ECG data and backed by 31 peer-reviewed scientific publications in top journals like Nature and Circulation, idoven.ai’s Willem™ platform delivers cardiologist-level insights with 92.8% accuracy in atrial fibrillation detection. Designed for seamless integration across medical and pharmaceutical ecosystems, it supports a wide range of ECG devices and data formats, empowering clinicians, researchers, and life sciences organizations to improve early diagnosis—especially in conditions like amyloidosis—and enhance patient outcomes through real-time monitoring, digital biomarkers, and risk stratification.

Key Features:

• Willem™ AI-Powered ECG Analysis Platform: Certified as a Medical Device Class IIa under EU MDR, delivering expert-level ECG interpretation.
• 22 Cardiac Pattern Detection: Identifies subtle electrical anomalies in ECGs, including arrhythmias and conduction issues.
• 4 Interval Measurements: Analyzes P Interval, PR Interval, QT Interval, and QRS duration with clinical precision.
• Device-Neutral Data Ingestion: Accepts ECG data from 1-lead, 2-lead, 12-lead, and insertable cardiac monitors (ICM).
• Multi-Format Support: Compatible with EDF, HL7, DICOM, JSON, XML, and PDF formats for flexible integration.
• Real-Time Analysis & Rapid Results: Processes ECGs of any duration (30 seconds to 30 days) and delivers results in minutes.
• Integration with EMR & Home Monitoring Systems: Seamlessly connects with Electronic Health Record (EHR) and remote patient monitoring platforms via API and non-API methods.
• Preventative Screening & Pharma-Ready Biomarkers: Supports pre-initiation ECG testing and cardiovascular safety monitoring in clinical trials and post-market approval.
• Digital Biomarkers & Risk Stratification: Enables early identification of patients at risk for chronic conditions like heart failure, stroke, and kidney disease.
• Cardiotoxicity Monitoring: Provides tools for tracking drug-induced cardiac risks in pharmaceutical research.
• Pioneering Research Collaboration: Actively involved in EU-funded consortia such as MAESTRIA, ASSIST, FAITHFUL, and ARISTOTELES, and leads the CONCERTO project with AstraZeneca for early amyloidosis diagnosis.
• High Clinical Accuracy & Validation: Trained on vast, expert-annotated datasets and validated in European hospitals.
• Compliance & Security: Fully compliant with GDPR, Spanish LOPD-GDD, and certified under ISO 27001, ISO 27017, ISO 27018, ISO 27701, and ISO 37001.
• Customizable Clinical Interface: Offers a tailored app for both cardiologists and non-specialists to visualize ECGs and results effectively.
• Global Health Accessibility Mission: Committed to expanding access to high-quality cardiac diagnostics through innovative technology.

Pricing: idoven.ai operates on a subscription-based model tailored for healthcare providers, research institutions, and pharmaceutical partners, with pricing available upon request.

Conclusion: idoven.ai stands as a transformative force in cardiology, combining rigorous scientific validation, medical device certification, and real-world clinical integration to deliver powerful AI-driven insights that enhance diagnostic accuracy, support preventive care, and accelerate pharmaceutical innovation—all while maintaining the highest standards in data security and compliance.